Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhicheng Lin

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Small Methods|August 20, 2025
Deciphering Closed-Pore Formation and Size-Dependent Sodium Cluster Filling Behavior for Nanopore-Confined Derived Hard Carbon AnodesChuang Qiu, Yawen Wu, Xinzhuo Mai, et al.
Sleep Medicine Reviews|October 11, 2025
Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanismsGuiying Kuang, Qinwei Yu, Danfang Yu, et al.
Behavioral and Brain Functions : BBF|December 12, 2012
Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central ChinaYoupei Wang, Ling Liu, Jing Xiong, et al.
Frontiers in Molecular Neuroscience|February 16, 2017
HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell ModelJinsha Huang, Jiaolong Yang, Yan Shen, et al.
Iscience|May 23, 2022
<i>Pearson</i>'s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreakJingwen Li, Xi Long, Qing Zhang, et al.
Molecular Neurobiology|August 5, 2024
Insomnia in Parkinson's Disease: Causes, Consequences, and Therapeutic ApproachesXiaoyu Duan, Hanshu Liu, Xinyu Hu, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2006
Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivoBertha K Madras, Michele A Fahey, Martin Goulet, et al.
Plos One|June 17, 2011
Edaravone guards dopamine neurons in a rotenone model for Parkinson's diseaseNian Xiong, Jing Xiong, Ghanshyam Khare, et al.
Schizophrenia Bulletin|December 29, 2015
Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsJames L Kennedy, Nian Xiong, Jinlong Yu, et al.
Frontiers in Aging Neuroscience|February 7, 2018
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future ProspectsKai Ma, Nian Xiong, Yan Shen, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Small Methods|August 20, 2025
Deciphering Closed-Pore Formation and Size-Dependent Sodium Cluster Filling Behavior for Nanopore-Confined Derived Hard Carbon AnodesChuang Qiu, Yawen Wu, Xinzhuo Mai, et al.
Sleep Medicine Reviews|October 11, 2025
Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanismsGuiying Kuang, Qinwei Yu, Danfang Yu, et al.
Behavioral and Brain Functions : BBF|December 12, 2012
Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central ChinaYoupei Wang, Ling Liu, Jing Xiong, et al.
Frontiers in Molecular Neuroscience|February 16, 2017
HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell ModelJinsha Huang, Jiaolong Yang, Yan Shen, et al.
Iscience|May 23, 2022
<i>Pearson</i>'s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreakJingwen Li, Xi Long, Qing Zhang, et al.
Molecular Neurobiology|August 5, 2024
Insomnia in Parkinson's Disease: Causes, Consequences, and Therapeutic ApproachesXiaoyu Duan, Hanshu Liu, Xinyu Hu, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2006
Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivoBertha K Madras, Michele A Fahey, Martin Goulet, et al.
Plos One|June 17, 2011
Edaravone guards dopamine neurons in a rotenone model for Parkinson's diseaseNian Xiong, Jing Xiong, Ghanshyam Khare, et al.
Schizophrenia Bulletin|December 29, 2015
Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsJames L Kennedy, Nian Xiong, Jinlong Yu, et al.
Frontiers in Aging Neuroscience|February 7, 2018
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future ProspectsKai Ma, Nian Xiong, Yan Shen, et al.
Pageof 20